Orchid Pharma Limited — Others, 26-06-2025: Disclosure under SEBI Takeover Regulations

Dhanuka Laboratories has announced no new encumbrance on shares of Orchid Pharma during the current financial year, confirming that neither it nor its concert parties have created any fresh charge or lien on their holdings beyond previously disclosed ones. This update reassures shareholders about the promoter’s clean shareholding status, indicating no additional borrowing or collateralization involving Orchid Pharma’s equity.